los angeles reuters kaiser permanente biggest us health maintenance organization said using gilead sciences new hepatitis c drug sovaldi even though 8400 treatment price outrageous
medication widely viewed breakthrough cure majority hepatitis c patients often within 12 weeks analysts project 2017 sales 91 billion according thomson reuters pharma
gilead come fire insurers congress sovaldis 100apill price time us healthcare spending scrutiny president barack obamas affordable care act aims make health coverage accessible everyone
company says sovaldi create huge savings healthcare system time preventing complications liver disease transplants declined requests evidence back claims gilead executive told reuters last week agreement discount drug kaiser network based recognition longterm benefits
interview kaiser officials disputed view kaiser using sovaldi see highvalue costeffective approach said dr sharon levine associate director permanente medical group therapy represents substantial improvement existing therapies outrageous price therapy huge public health implications
called kaisers discount sovaldi modest said state medicaid programs private health insurers going make serious tradeoffs based single manufacturers decision pricing drug
hepatitis c estimated infect 32 million americans bloodborne virus cause severe liver damage
democratic lawmakers house representatives led californias henry waxman asked gilead explain sovaldis pricing company said met committee staff monday
public call gilead congress sent shock waves biotech investment community raising concerns leading drugmakers could face pressure pricing new medicines past month nasdaq biotechnology index fallen 8 percent
insurers state officials running medicaid health program poor fear multibilliondollar tab sovaldi alone
investment bank leerink partners estimates drugs cost could trim much 10 percent earnings publicly traded health insurers
kaiser nonprofit said sovaldi material portion drug budget cost ultimately born members employers pay insurance premiums
comes back question benefits time enormous pressure ensure cost healthcare cost providing access cures doesnt bankrupt rest investments country needs make levine said
